ELANCO ANIMAL HEALTH INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.26 USD | +1.69% |
|
+2.39% | -11.01% |
| 04-01 | Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board | MT |
| 04-01 | Elanco appoints two directors after settling with activist Ancora | RE |
Chart calendar Elanco Animal Health Incorporated
406fca3ca.6HP_sSwDBlQvQ3RuPDIOTDUAkVRv8tpkiRKnZXJeIEY.kguV0B1IQixJMyAqSX1kB28w9zUhh-1JvVjXABw4TgOKCqf6W2FPYn0zNQ~50e9784c92f70b8d190aa8bfae94fc70
Upcoming events on Elanco Animal Health Incorporated
Past events on Elanco Animal Health Incorporated
| 12/03/2024 20:05 | Barclays Global Healthcare Conference |
| 04/03/2024 15:30 | TD Cowen Health Care Conference |
| 29/02/2024 19:10 | Bank of America Securities Animal Health Summit |
| 26/02/2024 13:00 | Q4 2023 Earnings Call |
| 26/02/2024 11:27 | Q4 2023 Earnings Release |
| 09/01/2024 23:00 | JPMorgan Healthcare Conference |
| 29/11/2023 13:20 | Evercore ISI HealthCONx Conference |
| 07/11/2023 13:00 | Q3 2023 Earnings Call |
| 07/11/2023 11:33 | Q3 2023 Earnings Release |
| 11/09/2023 21:15 | Morgan Stanley Global Healthcare Conference |
| 07/08/2023 13:00 | Q2 2023 Earnings Call |
| 07/08/2023 11:33 | Q2 2023 Earnings Release |
| 12/06/2023 22:40 | Goldman Sachs Global Healthcare Conference |
| 01/06/2023 18:50 | Stifel Jaws and Paws Conference - Fireside Chat |
| 18/05/2023 13:00 | Annual General Meeting |
| 09/05/2023 13:00 | Q1 2023 Earnings Call |
| 09/05/2023 11:34 | Q1 2023 Earnings Release |
| 14/03/2023 12:30 | Barclays Global Healthcare Conference |
| 06/03/2023 19:10 | Cowen Health Care Conference |
| 02/03/2023 21:40 | Bank of America Health Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 071 3 074 -0.11% | 3 273 3 188 2.67% | 4 765 4 755 0.21% | 4 418 4 410 0.19% | 4 417 4 385 0.72% | 4 492 |
|
EBITDA Million USD | Released Forecast Spread | 663 668 -0.82% | 529 508 4.08% | 1 057 1 054 0.31% | 1 023 1 048 -2.41% | 979 990 -1.08% | 987 |
|
EBIT Million USD | Released Forecast Spread | 549 582 -5.69% | 214 386 -44.67% | 922 910 1.36% | 918 907 1.22% | 876 866 1.19% | 859 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1 248 |
|
Net income Million USD | Released Forecast Spread | 67,9 80,8 -15.94% | -560 -365 -53.31% | -472 -411 -14.86% | -74,0 -65,0 -13.93% | -1 231 -1 194 -3.14% | -36,3 |
|
EPS USD | Released Forecast Spread | 0,18 0,19 -7.43% | -1,27 -0,82 -54.88% | -0,97 -0,84 -15.02% | -0,15 -0,15 0% | -2,50 -2,40 -4.25% | -0,08 |
| Announcement Date | 19/02/20 | 24/02/21 | 24/02/22 | 21/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 113 1 102 0.99% | 1 225 1 220 0.42% | 1 177 1 176 0.08% | 1 028 1 029 -0.07% | 988 981 0.72% | 1 257 1 180 6.51% | 1 057 1 040 1.68% | 1 068 1 043 2.42% | 1 035 1 003 3.16% | 1 175 | 1 158 | 1 093 | 1 074 | 1 226 |
|
EBITDA Million USD | Released Forecast Spread | 212 207 2.58% | 339 319 6.11% | 300 258 16.2% | 205 202 1.31% | 174 183 -4.92% | 379 285 33.1% | 222 145 53.28% | 214 187 14.3% | 165 171 -3.28% | 264 | 262 | 229 | 232 | 306 |
|
EBIT Million USD | Released Forecast Spread | 180 169 6.51% | 315 276 13.97% | 284 213 33.06% | 180 167 7.72% | 157 147 6.82% | 354 256 38.14% | 210 114 83.61% | 183 161 13.95% | 148 146 1.18% | 242 | 230 | 198 | 198 | 286 |
|
Net income Million USD | Released Forecast Spread | -97,0 -36,0 -169.82% | 48,0 34,9 37.73% | -22,0 20,5 -207.49% | -49,0 -36,5 -34.12% | -54,0 -42,1 -28.42% | 103 -0,15 68766.67% | -97,0 -125 22.65% | -1 096 -78,7 -1293.52% | -141 -98,3 -43.44% | -19,4 | -0,85 | -17,3 | -6,95 | 46,0 |
|
EPS USD | Released Forecast Spread | -0,20 -0,10 -110.53% | 0,10 0,03 300% | -0,04 -0,04 -14.29% | -0,10 -0,08 -25% | -0,11 -0,11 -4.76% | 0,21 0,00 - | -0,20 -0,26 22.08% | -2,22 -0,16 -1316.99% | -0,29 -0,19 -55.35% | -0,02 | 0,01 | -0,04 | -0,02 | 0,08 |
| Announcement Date | 24/02/22 | 09/05/22 | 08/08/22 | 08/11/22 | 21/02/23 | 09/05/23 | 07/08/23 | 07/11/23 | 26/02/24 | - | - | - | - | - |
| 28/04/2024 | VETOQUINOL SA: Q1 2024 Sales and Revenue Release |
| 29/04/2024 | SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
| 02/05/2024 06:45 | VIMIAN GROUP AB: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | ZOETIS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | ELANCO ANIMAL HEALTH INCORPORATED: Q1 2024 Earnings Release |
| 07/05/2024 | PHIBRO ANIMAL HEALTH CORPORATION: Q3 2024 Earnings Release |
| 15/07/2024 | VIRBAC: Q2 2024 Sales and Revenue Release |
| 24/07/2024 | SWEDENCARE AB: Q2 2024 Earnings Release |
Past sector events for Elanco Animal Health Incorporated
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ELAN Stock
- Calendar Elanco Animal Health Incorporated
